- €111.54m
- €88.56m
- €248.14m
Brief: Haemato To Decrease Share Capital
Brief: M1 Kliniken Acquires About 48 Procent Of Shares Of Haemato
Brief: Haemato Postpones AGM, Date To Be Disclosed Later
Brief: Haemato Q1 EBITDA Down At EUR 954,000
Brief: Haemato FY Operating Profit Swings Into Loss Of EUR 19,000
Brief: Haemato Approves Appropriation Of Profits Proposal
Brief: Haemato FY Net Profit At EUR -1.17 Mln
Brief: Haemato 9-Month EBITDA Down At EUR 1.6 Million
Brief: Haemato H1 EBITDA Of EUR 1.69 Mln
Brief: Haemato Q1 Consolidated Revenues Down At EUR 48.4 Mln
Brief: Haemato 9-Mth Net Income At EUR 5.87 Mln
Brief: Haemato H1 EBIT At EUR 6.5 Mln
Brief: Haemato Q1 EBIT Amounted To EUR 4.0 Mln
Brief: Haemato FY Net Profit Down At EUR 6.98 Million
Brief: Haemato Q3 Sales Up At EUR 72.5 Mln
Brief: Haemato H1 net profit down at 2.164 mln euros
Brief: Haemato appoints Uwe Zimdars new CEO, Daniel Kracht new CFO
Brief: Haemato decides on capital increase from authorized capital
Brief: MPH Mittelstaendische Pharma Holding FY net profit down at 81.45 million euros